EI
TXG icon

Ethic Inc’s 10x Genomics TXG Stock Holding History

Ethic Inc’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$586K Buy
15,295
+469
+3% +$12.3K 0.01% 891
2026
Q1 		$315K Sell
14,826
-480
-3% -$9.6K ﹤0.01% 1023
2025
Q4 		$250K Sell
15,306
-2,449
-14% -$37K ﹤0.01% 1066
2025
Q3 		$208K Sell
17,755
-6,857
-28% -$89.4K ﹤0.01% 1110
2025
Q2 		$289K Buy
+24,612
New +$224K 0.01% 992
2023
Q3 		– Sell
-4,925
Closed -$275K – 1062
2023
Q2 		$275K Sell
4,925
-1,867
-27% -$101K 0.01% 813
2023
Q1 		$379K Sell
6,792
-809
-11% -$37.8K 0.02% 733
2022
Q4 		$277K Buy
+7,601
New +$249K 0.02% 745
2022
Q2 		– Sell
-3,018
Closed -$230K – 790
2022
Q1 		$230K Buy
3,018
+936
+45% +$81.9K 0.02% 672
2021
Q4 		$310K Buy
2,082
+273
+15% +$41.8K 0.02% 521
2021
Q3 		$263K Sell
1,809
-91
-5% -$15.6K 0.03% 510
2021
Q2 		$372K Buy
+1,900
New +$344K 0.05% 407

Other funds holding TXG

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Ethic Inc's TXG Position: Q2 2026 in Review

Ethic Inc increased its 10x Genomics (TXG) stake by 3.2% in Q2 2026, buying an estimated $12.3K and bringing the position to 15,295 shares worth $586K. The position accounts for 0.01% of the portfolio, ranked #891.

Ethic Inc first reported a position in TXG in Q2 2021 and has held it in 12 quarters since. 88 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Ethic Inc held 15,295 shares of 10x Genomics worth $586K as of Q2 2026.
  • Ethic Inc bought 469 10x Genomics shares in Q2 2026, an estimated $12.3K.
  • 10x Genomics made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #891 holding.
  • Ethic Inc first reported a position in 10x Genomics in Q2 2021 and has held it in 12 quarters since.
  • 88 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.